Inflammation and In-Stent Restenosis: The Role of Serum Markers and Stent Characteristics in Carotid Artery Stenting
Author Information
Author(s): Wasser Katrin, Schnaudigel Sonja, Wohlfahrt Janin, Psychogios Marios-Nikos, Knauth Michael, Gröschel Klaus
Primary Institution: University of Göttingen, Göttingen, Germany
Hypothesis
The study investigates the influence of inflammatory serum markers and procedure-related factors on in-stent restenosis (ISR) after carotid artery stenting.
Conclusion
In-stent restenosis is associated with periinterventional inflammation markers and influenced by stent characteristics such as length and width.
Supporting Evidence
- 5.7% of patients experienced in-stent restenosis after a median follow-up of 33.4 months.
- Leukocyte count after the procedure was significantly associated with the development of ISR.
- Stent length and width were also significant predictors of ISR.
Takeaway
Doctors looked at how inflammation and stent design affect blockages in arteries after a procedure. They found that certain blood markers and the size of the stent can help predict these blockages.
Methodology
The study analyzed 210 carotid artery stenting procedures in 194 patients, examining serum markers and stent characteristics in relation to ISR.
Potential Biases
Potential ascertainment bias due to the retrospective nature of the analysis.
Limitations
The study was retrospective, which may introduce bias, and the techniques for carotid artery stenting have improved over time.
Participant Demographics
Mean age of 67.9 years, 71.9% male, 71.0% symptomatic carotid stenosis.
Statistical Information
P-Value
0.022
Confidence Interval
1.02–1.69
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website